Back
Results - Announcements
Sales rise 3.45% to Rs 36.89 crore
Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter
29-Jan-2025, 07:38
Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 2024 as against Rs 5.40 crore during the previous quarter ended December 2023. Sales rose 3.45% to Rs 36.89 crore in the quarter ended December 2024 as against Rs 35.66 crore during the previous quarter ended December 2023.
Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 2024 as against Rs 5.40 crore during the previous quarter ended December 2023. Sales rose 3.45% to Rs 36.89 crore in the quarter ended December 2024 as against Rs 35.66 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 36.89 | 35.66 | 3 |
| OPM % | 23.94 | 20.16 | - |
| PBDT | 10.30 | 8.47 | 22 |
| PBT | 9.52 | 7.84 | 21 |
| NP | 6.51 | 5.40 | 21 |
Powered by Capital Market - Live News